首页> 外文会议>International Symposium on VIP, PACAP, and Related Peptides >Mechanisms of VIP-Induced Neuroprotection against Neonatal Excitotoxicitv
【24h】

Mechanisms of VIP-Induced Neuroprotection against Neonatal Excitotoxicitv

机译:对新生儿excitotoxicatv的抑制神经保护机制

获取原文

摘要

Two VIP receptors, shared with a similar affinity by pituitary adenylate cyclase-activating polypeptide (PACAP), have been cloned: VPACI and VPAC2. PHI binds to these receptors with a lower affinity. We previously showed that VIP protects against excitotoxic white matter damage in newborn mice. This article aimed to determine the receptor in-volved in VIP-induced neuroprotection. VIP effects were mimicked with a similar potency by VPAC2 agonists and PHI but not by VPAC1 agonists, PACAP 27 or PACAP 38. VIP neuroprotective effects were lost in mice lacking VPAC2 receptor. In situ hybridization confirmed the presence of VPAC2 mRNA. These data suggest that, in this model, VIP-induced neuroprotection is mediated by VPAC2 receptors. The pharmacology of this VPAC2 receptor seems unconventional as PACAP does not mimic VIP effects and PHI acts with a comparable potency.
机译:已经克隆了两种与垂体腺苷酸环酶激活多肽(PACAP)相似亲和性的VIP受体:VPACI和VPAC2。 PHI与较低亲和力的受体结合。我们以前表明VIP在新生儿小鼠中保护抗吞噬毒性白质损伤。本文旨在确定VIP诱导的神经保护中受体的受体。 VPAC2激动剂和PHI的vip效应模仿了类似的效力,而不是由VPAC1激动剂,PACAP 27或PACAP 38.缺乏VPAC2受体的小鼠丧失VIP神经保护作用。原位杂交证实存在VPAC2 mRNA的存在。这些数据表明,在该模型中,VIP诱导的神经保护由VPAC2受体介导。该VPAC2受体的药理学似乎非常规似乎是PACAP不模仿VIP效应和PHI与可比效力的作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号